DOI:
10.1055/s-00000142
Frauenheilkunde up2date
LinksClose Window
References
Mahadevan U, Vermeire S, Lasch K. et al.
Vedolizumab exposure in pregnancy: outcomes from clinical studies in inflammatory bowel disease.
Aliment Pharmacol Ther 2017;
45: 941-950
We do not assume any responsibility for the contents of the web pages of other providers.